ProQR Therapeutics NV (PRQR)
1.95
+0.12
(+6.56%)
USD |
NASDAQ |
May 31, 16:00
1.95
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Cash from Investing (Quarterly): -19.26M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -19.26M |
| December 31, 2023 | 5.418M |
| September 30, 2023 | -0.3685M |
| June 30, 2023 | -0.322M |
| March 31, 2023 | -0.0956M |
| December 31, 2022 | -0.014M |
| September 30, 2022 | -0.2204M |
| June 30, 2022 | -0.2322M |
| March 31, 2022 | -0.2738M |
| December 31, 2021 | -0.1975M |
| September 30, 2021 | -0.2041M |
| June 30, 2021 | -0.0627M |
| March 31, 2021 | -0.0386M |
| December 31, 2020 | -0.1127M |
| September 30, 2020 | -0.3456M |
| June 30, 2020 | -0.3784M |
| March 31, 2020 | -0.2185M |
| December 31, 2019 | -0.2701M |
| September 30, 2019 | -0.032M |
| June 30, 2019 | -0.0938M |
| March 31, 2019 | -0.2533M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.037M |
| September 30, 2018 | -0.1093M |
| June 30, 2018 | -0.2172M |
| March 31, 2018 | -0.0049M |
| December 31, 2017 | -0.0065M |
| September 30, 2017 | -0.0282M |
| June 30, 2017 | -0.0544M |
| March 31, 2017 | -0.0479M |
| December 31, 2016 | -0.0253M |
| September 30, 2016 | -0.4427M |
| June 30, 2016 | -1.788M |
| March 31, 2016 | -0.5538M |
| December 31, 2015 | -0.2234M |
| September 30, 2015 | -0.0689M |
| June 30, 2015 | -0.6263M |
| March 31, 2015 | -0.5506M |
| December 31, 2014 | -0.8525M |
| September 30, 2014 | -0.4443M |
| June 30, 2014 | -0.1292M |
| March 31, 2014 | -0.2137M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-19.26M
Minimum
Mar 2024
5.418M
Maximum
Dec 2023
-0.8662M
Average
-0.2113M
Median
Cash from Investing (Quarterly) Benchmarks
| uniQure NV | 63.98M |
| Merus NV | -12.08M |
| argenx SE | -- |
| Pharming Group | 0.664M |
| Pharvaris NV | -0.0334M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.44M |
| Cash from Financing (Quarterly) | -0.4551M |
| Free Cash Flow | -43.28M |
| Free Cash Flow Per Share (Quarterly) | -0.2112 |
| Free Cash Flow to Equity (Quarterly) | -17.20M |
| Free Cash Flow to Firm (Quarterly) | -17.23M |
| Free Cash Flow Yield | -27.34% |